Immunohaematology blood grouping antisera IVDs

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Verfügbar ab:

Grifols Australia Pty Ltd

Klasse:

Class 4

Hergestellt von:

Grifols Australia Pty Ltd Unit 5/80 Fairbank Road, CLAYTON SOUTH, VIC, 3169 Australia

Therapiebereich:

CT887 - Immunohaematology blood grouping antisera IVDs

Anwendungsgebiete:

Immunoglobulins capable of binding to specific red blood cell antigens and intended to be used in immunohaematological testing to provide information about red blood cell antigen phenotypes. Immunoglobulins capable of binding to specific red blood cell antigens and intended to be used in immunohaematological testing to provide information about red blood cell antigen phenotypes.

Berechtigungsstatus:

A

Berechtigungsdatum:

2015-03-20